Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

B Diijkshoorn; Daisy Vedder; D.C. Nordström; B. Gudbjørnsson; K Lend; T Uhlig; Gerdur Gröndal; E.A. Haavardsholm; Merete Lund Hetland; M Heiberg; Mikkel Østergaard; K Hørslev-Petersen; Jon Lampa; R. van Vollenhoven; A Antovic; Michael Nurmohamed

Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

B Diijkshoorn, Daisy Vedder, D.C. Nordström, B. Gudbjørnsson, K Lend, T Uhlig, Gerdur Gröndal, E.A. Haavardsholm, Merete Lund Hetland, M Heiberg, Mikkel Østergaard, K Hørslev-Petersen, Jon Lampa, R. van Vollenhoven, A Antovic, Michael Nurmohamed

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Abstract

Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.

Originalsprog	Engelsk
Publikationsdato	2022
Status	Udgivet - 2022
Begivenhed	ACR 2022 - Philadelphia Varighed: 10 nov. 2022 → 14 nov. 2022

Konference

Konference	ACR 2022
By	Philadelphia
Periode	10/11/2022 → 14/11/2022

Citationsformater

Diijkshoorn, B., Vedder, D., Nordström, D. C., Gudbjørnsson, B., Lend, K., Uhlig, T., Gröndal, G., Haavardsholm, E. A., Hetland, M. L., Heiberg, M., Østergaard, M., Hørslev-Petersen, K., Lampa, J., van Vollenhoven, R., Antovic, A., & Nurmohamed, M. (2022). Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study. Arthritis & Reumatology Vol. 74, number S9, p. 3183. Abstract fra ACR 2022, Philadelphia.

Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study. / Diijkshoorn, B; Vedder, Daisy; Nordström, D.C. et al.
2022. Arthritis & Reumatology Vol. 74, number S9, p. 3183 Abstract fra ACR 2022, Philadelphia.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

Diijkshoorn, B, Vedder, D, Nordström, DC, Gudbjørnsson, B, Lend, K, Uhlig, T, Gröndal, G, Haavardsholm, EA, Hetland, ML, Heiberg, M, Østergaard, M, Hørslev-Petersen, K, Lampa, J, van Vollenhoven, R, Antovic, A & Nurmohamed, M 2022, 'Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study', ACR 2022, Philadelphia, 10/11/2022 - 14/11/2022 s. Arthritis & Reumatology Vol. 74, number S9, p. 3183.

@conference{e67fedcad9204dd6b9151401ba74ee1f,

title = "Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study",

abstract = "Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.",

author = "B Diijkshoorn and Daisy Vedder and D.C. Nordstr{\"o}m and B. Gudbj{\o}rnsson and K Lend and T Uhlig and Gerdur Gr{\"o}ndal and E.A. Haavardsholm and Hetland, {Merete Lund} and M Heiberg and Mikkel {\O}stergaard and K H{\o}rslev-Petersen and Jon Lampa and {van Vollenhoven}, R. and A Antovic and Michael Nurmohamed",

note = "COPECARE; ACR 2022 ; Conference date: 10-11-2022 Through 14-11-2022",

year = "2022",

language = "English",

pages = "Arthritis & Reumatology Vol. 74, number S9, p. 3183",

}

TY - ABST

T1 - Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

AU - Diijkshoorn, B

AU - Vedder, Daisy

AU - Nordström, D.C.

AU - Gudbjørnsson, B.

AU - Lend, K

AU - Uhlig, T

AU - Gröndal, Gerdur

AU - Haavardsholm, E.A.

AU - Hetland, Merete Lund

AU - Heiberg, M

AU - Østergaard, Mikkel

AU - Hørslev-Petersen, K

AU - Lampa, Jon

AU - van Vollenhoven, R.

AU - Antovic, A

AU - Nurmohamed, Michael

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.

AB - Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the effects of initial antirheumatic treatments in (very) early RA patients. Therefore our objective was to assess the effects of different initial treatments on hemostatic parameters in patients with early RA.

M3 - Conference abstract for conference

SP - Arthritis & Reumatology Vol. 74, number S9, p. 3183

T2 - ACR 2022

Y2 - 10 November 2022 through 14 November 2022

ER -

Profound anticoagulant effects of initial antirheumatic treatments in early rheumatoid arthritis patients: a NORDSTAR spin-off study

Abstract

Konference

Fingeraftryk

Citationsformater